Coexistence of Gaucher Disease and severe congenital neutropenia

被引:4
作者
Kose, Melis Demir [1 ]
Canda, Ebru [2 ]
Kagnici, Mehtap [1 ]
Ucar, Sema Kalkan [2 ]
Onay, Huseyin [3 ]
Sozmen, Eser Yildirim [4 ]
Karapinar, Deniz [5 ]
Ozkinay, Ferda [3 ]
Coker, Mahmut [2 ]
机构
[1] Behcet Uz Children Training & Res Hosp, Pediat Metab Dept, Izmir, Turkey
[2] Ege Univ, Pediat Metab Dept, Fac Med, Izmir, Turkey
[3] Ege Univ, Dept Genet, Fac Med, Izmir, Turkey
[4] Ege Univ, Dept Med Biochem, Fac Med, Izmir, Turkey
[5] Ege Univ, Dept Pediat Hematol, Fac Med, Izmir, Turkey
关键词
Enzyme replacement therapy; Gaucher disease; GBA gene; HAX1; gene; Neutropenia; Kostmann syndrome; PROTEIN X-1; CHEMOTAXIS; PHENOTYPE; HAX-1;
D O I
10.1016/j.bcmd.2018.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gaucher Disease (GD) is the most common lysosomal storage disorder has traditionally been classified into three clinical phenotypes. Type 3 GD is characterized by neurological involvement but neurological symptoms generally appear later in life than in type 2 disease. Neutropenia is much rarer than other hematological manifestations in GD and has not been scrutinized adequately. Severe congenital neutropenia (SCN) is a rare disease entity which is characterized by a paucity of peripherally circulating neutrophils with arrest of neutrophil maturation at the promyelocyte stage and consequent increased susceptibility to severe and recurrent infections. We report a patient who presented in the first year of life with visceral involvement and severe neutropenia in whom the propositus had a unique coexistence of Gaucher Disease and severe congenital neutropenia associated with a mutation in HAX1. In contrast to his expired siblings he had experienced no severe infections. These clinical observations suggest that enzyme replacement therapy may display a modulating factor with respect to the clinical course of SCN. Synopsis: Our patient is the only report of the combination of Gaucher Disease and Kostmann Syndrome in the literature. The clinical course of our patient is not severe when comparing with exitus siblings and other Kostmann Syndrome patients. But when considering the patient's only clinical difference is ERT, this case is very important to emphasise the role of enzyme replacement therapy in bone marrow.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] Ovarian failure in HAX1-deficient patients: is there a gender-specific difference in pubertal development in severe congenital neutropenia or Kostmann disease?
    Carlsson, Goran
    Kristrom, Berit
    Nordenskjold, Magnus
    Henter, Jan-Inge
    Fadeel, Bengt
    ACTA PAEDIATRICA, 2013, 102 (01) : 78 - 82
  • [32] Different Pattern of Gene Mutations in Iranian Patients with Severe Congenital Neutropenia (Including 2 New Mutations)
    Alizadeh, Zahra
    Fazlollahi, Mohammad Reza
    Houshmand, Massoud
    Maddah, Marzieh
    Chavoshzadeh, Zahra
    Hamidieh, Amir Ali
    Shamsian, Bibi Shahin
    Eshghi, Payman
    Pour, Samaneh Bolandghamat
    Jahromi, Hoda Sadaaie
    Mansouri, Mahboobeh
    Movahedi, Masoud
    Nayebpour, Mohsen
    Pourpak, Zahra
    Moin, Mostafa
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2013, 12 (01) : 86 - 92
  • [33] Severe Congenital Neutropenia in 2 Siblings of Consanguineous Parents. The Role of HAX1 Deficiency
    Mamishi, S.
    Esfahani, S. A.
    Parvaneh, N.
    Diestelhorst, J.
    Rezaei, N.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2009, 19 (06) : 500 - 503
  • [34] SEVERE CONGENITAL NEUTROPENIA IN TWO SIBLINGS RELATED TO HAX1 MUTATION WITHOUT NEURODEVELOPMENTAL DISORDERS
    Patiroglu, T.
    Gungor, H. Eke
    Triot, A.
    Unal, E.
    GENETIC COUNSELING, 2013, 24 (03): : 253 - 258
  • [35] Defective Sec61α1 underlies a novel cause of autosomal dominant severe congenital neutropenia
    Van Nieuwenhove, Erika
    Barber, John S.
    Neumann, Julika
    Smeets, Elien
    Willemsen, Mathijs
    Pasciuto, Emanuela
    Prezzemolo, Teresa
    Lagou, Vasiliki
    Seldeslachts, Laura
    Malengier-Devlies, Bert
    Metzemaekers, Mieke
    Hassdenteufel, Sarah
    Kerstens, Axelle
    van der Kant, Rob
    Rousseau, Frederic
    Schymkowitz, Joost
    Di Marino, Daniele
    Lang, Sven
    Zimmermann, Richard
    Schlenner, Susan
    Munck, Sebastian
    Proost, Paul
    Matthys, Patrick
    Devalck, Christine
    Boeckx, Nancy
    Claessens, Frank
    Wouters, Carine
    Humblet-Baron, Stephanie
    Meyts, Isabelle
    Liston, Adrian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (05) : 1180 - 1193
  • [36] Compound Heterozygous HAX1 Mutations in a Swedish Patient With Severe Congenital Neutropenia and No Neurodevelopmental Abnormalities
    Carlsson, Goran
    Elinder, Goran
    Malmgren, Helena
    Trebinska, Alicja
    Grzybowska, Ewa
    Dahl, Niklas
    Nordenskjold, Magnus
    Fadeel, Bengt
    PEDIATRIC BLOOD & CANCER, 2009, 53 (06) : 1143 - 1146
  • [37] A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations
    Faiyaz-Ul-Haque, Muhammad
    Al-Jefri, Abdullah
    Al-Dayel, Fouad
    Bhuiyan, Jalaluddin A. K. M.
    Abalkhail, Hala A.
    Al-Nounou, Randa
    Al-Abdullatif, Ahmed
    Pulicat, Monogaran S.
    Gaafar, Ameera
    Alaiya, Ayodele A.
    Peltekova, Iskra
    Zaidi, Syed H. E.
    EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (06) : 661 - 666
  • [38] Game of clones: the genomic evolution of severe congenital neutropenia
    Touw, Ivo P.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 1 - 7
  • [39] Hematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia
    Carlsson, G.
    Winiarski, J.
    Ljungman, P.
    Ringden, O.
    Mattsson, J.
    Nordenskjold, M.
    Touw, I.
    Henter, J-I
    Palmblad, J.
    Fadeel, B.
    Hagglund, H.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (03) : 444 - 451
  • [40] Congenital neutropenia: disease models guiding new treatment strategies
    Touw, Ivo P.
    CURRENT OPINION IN HEMATOLOGY, 2022, 29 (01) : 27 - 33